Cargando…

The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low‐grade gliomas and potential therapeutic approaches

INTRODUCTION: Low‐grade gliomas (LGGs) are currently considered a premalignant condition for high‐grade gliomas (HGGs) and are characterized by a relatively intact immune system. Immunotherapeutic modalities may offer a safe and effective treatment option for these patients. However, the CD2–CD58 ax...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Mingwei, Chen, Yiyuan, Hua, Gao, Chunhui, Liu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571499/ https://www.ncbi.nlm.nih.gov/pubmed/37904707 http://dx.doi.org/10.1002/iid3.1022

Ejemplares similares

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2021)

Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
por: Li, Yong, et al.
Publicado: (2020)

Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis
por: Liu, Yan, et al.
Publicado: (2020)

Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2
Publicado: (1993)

Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients
por: Kinker, Gabriela Sarti, et al.
Publicado: (2016)

A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma
por: Liu, Wentao, et al.
Publicado: (2021)

CD58 Immunobiology at a Glance
por: Zhang, Yalu, et al.
Publicado: (2021)

Pyroptosis-Related Genes as Markers for Identifying Prognosis and Microenvironment in Low-Grade Glioma
por: Han, Jinkun, et al.
Publicado: (2023)

Midkine activation of CD8(+) T cells establishes a neuron–immune–cancer axis responsible for low-grade glioma growth
por: Guo, Xiaofan, et al.
Publicado: (2020)

High-expression of Galactosidase alpha is correlated with poor prognosis and immune infiltration in low-grade glioma
por: Zhang, Yi, et al.
Publicado: (2023)

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
por: Wang, Gang, et al.
Publicado: (2022)

Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas
por: Fan, Kun, et al.
Publicado: (2017)

LGG-58. Understanding the transcriptional heterogeneity of pediatric low-grade gliomas and its implication for tumor pathophysiology
por: Boisvert, Michelle, et al.
Publicado: (2022)

IGFBPs were associated with stemness, inflammation, extracellular matrix remodeling and poor prognosis of low-grade glioma
por: Liu, Zhihui, et al.
Publicado: (2022)

Implications of CRNDE in prognosis, tumor immunity, and therapeutic sensitivity in low grade glioma patients
por: Yang, Chen, et al.
Publicado: (2023)

MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

CD73 as a novel marker for poor prognosis of oral squamous cell carcinoma
por: REN, ZHEN-HU, et al.
Publicado: (2016)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-Expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma
por: Rebetz, Johan, et al.
Publicado: (2008)

CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer
por: Liu, Wen-Fang, et al.
Publicado: (2012)

CD34 Over-Expression is Associated With Gliomas’ Higher WHO Grade
por: Kong, Xiangyi, et al.
Publicado: (2016)

Therapeutic Interventions in Adult Low-Grade Gliomas
por: Chammas, Majid, et al.
Publicado: (2019)

CD5 and CD43 Expression are Associate with Poor Prognosis in DLBCL Patients
por: Huang, Hui, et al.
Publicado: (2018)

Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma
por: Lu, Jiajie, et al.
Publicado: (2021)

Elevated RECQL1 expression predicts poor prognosis and associates with tumor immune infiltration in low-grade glioma
por: Wang, Guiyuan, et al.
Publicado: (2022)

Genetic variants at CD28, PRDM1, and CD2/CD58 are associated with rheumatoid arthritis risk
por: Raychaudhuri, Soumya, et al.
Publicado: (2009)

Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas
por: Penman, Catherine Louise, et al.
Publicado: (2015)

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients
por: Jia, Yulong, et al.
Publicado: (2022)

CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression
por: Xiao, Yong, et al.
Publicado: (2022)

Decreased peripheral CD4(+)/CD8(+ )lymphocytes and poor prognosis in aged sepsis
por: Inoue, S, et al.
Publicado: (2012)

Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis
por: Wu, Bin, et al.
Publicado: (2015)

Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas
por: Du, Wei, et al.
Publicado: (2015)

Smoothened is a poor prognosis factor and a potential therapeutic target in glioma
por: Tu, Yiming, et al.
Publicado: (2017)

Antigen-Independent Maturation of CD2, CD11a/CD18, CD44, and CD58 Expression on Thymic Emigrants in Fetal and Postnatal Sheep
por: Witherden, Deborah A., et al.
Publicado: (1995)

Interfering with CALCRL expression inhibits glioma proliferation, promotes apoptosis, and predicts prognosis in low-grade gliomas
por: Gu, Shengcai, et al.
Publicado: (2022)

Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas
por: Zhang, Ming, et al.
Publicado: (2022)

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
por: Cao, Xueyuan, et al.
Publicado: (2014)

Costimulatory Function of Cd58/Cd2 Interaction in Adaptive Humoral Immunity in a Zebrafish Model
por: Shao, Tong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4923gba3fussoc20uiagdcuhnl